GlobeNewsWire
24 Jun 2026, 12:45 UTC · 13w ago
Verdict
Headline leans bullish. We score NTHI +0.90 across four claims.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+0.90strongly bullish
What the story claims
4 claims · scored −1 bearish … +1 bullish
NeOnc expects to report topline results from its fully enrolled NEO100-01 Phase 2a trial by the end of July.
More positive than 99% of claims this week
CEO Amir Heshmatpour has invested over $500,000 in open-market purchases recently, with total insider buying near $1 million over the last year.
Continue reading
5 related stories
More positive than 96% of ticker scores this week
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More positive than 86% of claims this week
The UAE Department of Health – Abu Dhabi granted IND status to NEO100 for adult and pediatric clinical protocols.
More positive than 65% of claims this week
NeOnc has access to a $75 million at-the-market facility and a $10 million line of credit.
So whatConfirmed liquidity reduces immediate bankruptcy risk and ensures the company can fund near-term operations.
More positive than 52% of claims this week
Which stocks this story touches
More positive than 96% of ticker scores this week
The company secured multiple IND authorizations in the UAE, has strong insider buying, and has upcoming Phase 2a clinical data results.
Near neutral — 92% of ticker scores this week are stronger
Mentioned only as an institutional holder of NTHI shares.
Near neutral — 92% of ticker scores this week are stronger
Mentioned only as an institutional holder of NTHI shares.
Near neutral — 92% of ticker scores this week are stronger
Mentioned only as an institutional holder of NTHI shares.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
MarketBeat
19h ago
More positive than 1% of relationship scores this week
[a_to_b] State Street is listed as an institutional holder of NeOnc Technologies Holdings.
More positive than 1% of relationship scores this week
[a_to_b] Barclays is listed as an institutional holder of NeOnc Technologies Holdings.
−32.2%
Price is moving against the score
$3.31 vs $4.88 close before publication (Jun 23) · not market-adjusted
NTHI chart →
